R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone), covering 2025-11-19 to 2025-11-19. Get the full timeline:
Most recent: Clinical Trial Update: R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma [Phase 2]